| Filed On | Filing |
|---|---|
| 10 Aug 2026 |
Form 4: Rottinghaus Scott T., Chief Medical Officer
Gave up 1,467 shares to cover exercise price or tax ($19.6K) |
| 13 Mar 2026 |
Form 4: Vance Terry, Director
Granted 20,000 Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4: Russell Lesley, Director
Granted 20,000 Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4: Peterson Kristine, Director
Granted 20,000 Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4: Hata Yujiro S, Director
Granted 20,000 Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4: Foletta Mark G, Director
Granted 20,000 Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4: Carter Bruce L A, Director
Granted 20,000 Stock Option (right to buy) |
| 13 Feb 2026 |
Form 4: Kowalsky Matthew Paul, Chief Legal Officer
Received 5,493 shares as a grant or award · Gave up 1,902 shares to cover exercise price or tax ($27.1K) |
| 13 Feb 2026 |
Form 4: Luu Brendan, Chief Business Officer
Received 6,562 shares as a grant or award · Gave up 3,257 shares to cover exercise price or tax ($46.4K) |
| 13 Feb 2026 |
Form 4: Kieffer Tara Lynn, Chief Product Strategy Officer
Received 6,562 shares as a grant or award · Gave up 3,257 shares to cover exercise price or tax ($46.4K) |
| 13 Feb 2026 |
Form 4: Rottinghaus Scott T., Chief Medical Officer
Received 6,875 shares as a grant or award · Gave up 3,413 shares to cover exercise price or tax ($48.6K) |
| 13 Feb 2026 |
Form 4: Or Yat Sun, Chief Scientific Officer
Received 6,875 shares as a grant or award · Gave up 3,413 shares to cover exercise price or tax ($48.6K) |
| 13 Feb 2026 |
Form 4: Luly Jay R., Director
Received 20,000 shares as a grant or award · Gave up 6,155 shares to cover exercise price or tax ($87.7K) |
| 05 Dec 2025 |
Form 4: Capps Kathleen S., See Remarks
Sold 323 shares ($4.6K) |
| 05 Dec 2025 |
Form 4: Trout Harry R. Iii, See Remarks
Sold 542 shares ($7.71K) |
| 05 Dec 2025 |
Form 4: Rottinghaus Scott T., Chief Medical Officer
Sold 798 shares ($11.4K) |
| 05 Dec 2025 |
Form 4: Luu Brendan, Chief Business Officer
Sold 1,394 shares ($19.8K) |
| 05 Dec 2025 |
Form 4: Kieffer Tara Lynn, Chief Product Strategy Officer
Sold 2,106 shares ($30K) |
| 05 Dec 2025 |
Form 4: Or Yat Sun, Chief Scientific Officer
Sold 2,390 shares ($34K) |
| 05 Dec 2025 |
Form 4: Luly Jay R., Director
Sold 4,743 shares ($67.5K) |
Loading...